Keyphrases
Acute Myeloid Leukemia
100%
Leukemia
79%
Ewing Sarcoma Family of Tumors
59%
CD19
45%
Acute Lymphoblastic Leukemia
41%
Tumor
37%
Acute Leukemia
36%
Immune-deficient Mice
36%
SCID Mice
35%
Leukemia Patients
35%
Pediatric
34%
Engraftment
33%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
32%
Bone Marrow
29%
Stem Cells
28%
CD34+
28%
Stem Cell Transplantation
28%
Tumor Cells
27%
Stem Cell Population
27%
Hematopoietic Stem Cell Transplantation
27%
Hematopoietic Cells
27%
Relapsed or Refractory
26%
Older Adults
26%
Event-free Survival
25%
Childhood Acute Lymphoblastic Leukemia
25%
T Cells
23%
Chimeric Antigen Receptor T Cells (CAR-T)
23%
Flow Cytometric
23%
Gene Therapy
23%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
22%
BCP-ALL
22%
Childhood Leukemia
21%
Transplantation
20%
Children with Cancer
20%
Hematopoiesis
20%
In Vivo Model
19%
Tumor Cell Lines
19%
High Risk
19%
Severe Combined Immunodeficient Mice
19%
Cell Population
19%
Immunophenotyping
19%
Down Syndrome
19%
Drug Development
18%
Phase II Trial
18%
Multilineage
18%
Total-body PET/CT
17%
Cellular Level
17%
Positron Emission Tomography-computed Tomography (PET-CT)
17%
Normal Stem Cells
17%
Tumor Cell Subpopulations
17%
Medicine and Dentistry
Acute Myeloid Leukemia
86%
Acute Lymphoblastic Leukemia
62%
Leukemia
54%
Pediatrics
51%
Neoplasm
50%
B Cell
38%
Precursor
33%
Stem Cell
30%
Cell Population
29%
Acute Myelogenous Leukemia
28%
Immunotherapy
28%
SCID Mouse
27%
Xenograft
27%
Adolescence
27%
Childhood Cancer
27%
Hematopoietic Stem Cell Transplantation
26%
Down Syndrome
24%
Oncology
23%
Malignant Neoplasm
22%
T Cell
22%
Metastatic Carcinoma
19%
Leukemia in Children
19%
Ewing Sarcoma
18%
Disease
17%
Chemotherapy
17%
Clinical Trial
17%
Positron Emission Tomography-Computed Tomography
17%
Whole Body PET
17%
Event Free Survival
16%
Auer Rod
16%
Personalized Medicine
16%
3 Hydroxyephedrine
16%
Normal Stem Cell
16%
Dexamethasone
16%
Iodine 123
16%
Radioactive Tracer
16%
Single Photon Emission Computed Tomography-Computed Tomography
16%
(3 Iodobenzyl)guanidine
16%
Sympathetic Nervous System
16%
Acute B-Cell Lymphoblastic Leukemia
16%
Carbon 11
15%
Receptor
13%
Reduced Intensity Conditioning
13%
Survival Rate
13%
Stem Cell Therapy
12%
Experimental Therapy
12%
Pediatric Cancer
11%
Central Nervous System
11%
Immunity
11%
Acute Leukemia
11%
Immunology and Microbiology
Stem Cell
69%
B Cell
62%
CD34
57%
Myeloid
51%
Precursor
47%
CD19
44%
SCID Mouse
42%
Cell Population
35%
T Cell
35%
Immunotherapy
34%
Hematopoiesis
31%
Cytokine
29%
Engraftment
29%
Tumor Cell
28%
Allogeneic Stem Cell Transplantation
26%
Hematopoietic Cell
25%
Event Free Survival
22%
Cell Subpopulation
19%
Cell Level
17%
Stem Cell Transplantation
17%
Tumor Cell Line
17%
Central Nervous System
16%
Chimera
16%
NOD SCID Mouse
16%
Lineages
15%
Epstein Barr Virus
15%
Immunology
15%
Human Cell
14%
Survival Rate
12%
Xenograft
12%
Adolescence
12%
Cell Adhesion Proteins
12%
Cell Death
12%
High Risk Population
12%
Bone Marrow Cell
11%
DNA Content
11%
Conditioning
11%
CD11a
10%
Antigen Expression
10%
Leukemia Cell
10%
Innate Lymphoid Cell
10%
Cytokine Receptor
10%
CD7
10%
Cord Blood Stem Cell Transplantation
10%
Gene Expression
9%
Drug Megadose
9%
Bone Marrow Transplantation
9%
CD117
9%
T Cell Receptor
9%
RNA Sequence
9%
